Continuous glucose monitors plus kaiawhina (healthcare assistant)-based care to support patients with Type 2 Diabetes in New Zealand

Not Applicable

Recruiting

• Conditions: type 2 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12624000438550
• Lead Sponsor: niversity of Waikato

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-10
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Inclusion: confirmed diagnosis of T2D for at least 1 year, HbA1c greater than or equal to 80mmol/mol (minimum two readings in 12 months prior to study), and prioritisation for Maori or Pacific ethnicity

Exclusion Criteria

Exclusion: pregnancy, previous bariatric surgery, glucocorticoid use, severe diabetic eye disease, and/or history of any previous cardiovascular events or diagnosis with renal failure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in HbA1c at 6 months[blood test (HbA1c) 6 months from the time each participant commences the study]

Secondary Outcome Measures

Name	Time	Method
Change in cardiovascular measurements (3, 6, 12 months) from the time that a participant commences enrolment into the study<br>[Lipids (blood test) 3, 6 and 12 months from the time each participant commences the study];diabetes self management / psychosocial scores[diabetes self management questionnaire 6 and 12 months from the time each participant commences the study (compared to baseline)];Change in HbA1c[HbA1c blood test 3 and 12 months from the time of participant commencing the study]